Cardiology Clinical Trials in Germantown, TN
As of July 2026, 9 paid clinical trials are recruiting for Cardiology in Germantown, Tennessee. Cardiology trials investigate SGLT-2 inhibitors, myosin modulators, lipid-lowering therapies, anti-inflammatory agents, and device-based interventions across heart failure, hypertension, AFib, and coronary artery disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
9 clinical trials for Cardiology
·Clear filters·↓ Download CSVBradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
CCM OPEN HF Registry
Pivotal Study for the Cardiac Performance System (CPS)
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Product Surveillance Registry
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
About research studies in Germantown
Germantown has approximately 91 recruiting research studies across a wide range of therapeutic areas. Tennessee is home to Vanderbilt University Medical Center and St. Jude Children's Research Hospital — world leaders in pediatric oncology and personalized medicine.
Top Research Study Locations in Germantown
Researchers run research studies in Germantown, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| The West Clinic, PLLC dba West Cancer Center | Breast Cancer, Advanced Malignant Tumors, Cancer of the Prostate | 10 |
| Campbell Clinic | Osteo Arthritis Knee, Pain, Postoperative, Acute Comminuted Articular Fracture of Elbow Joint Surfaces | 7 |
| Charles Retina Institute | Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration | 7 |
| West Cancer Center | Breast Cancer, Breast Neoplasms, Cancer | 7 |
| The West Clinic - Wolf River | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 6 |
| The Conrad Pearson Clinic | Benign Prostatic Hyperplasia (BPH), Non-Muscle Invasive Bladder Neoplasms, Radical Prostatectomy | 4 |
| The West Clinic | Biliary Tract Cancer, Hepatocellular Carcinoma, Metastatic Breast Cancer | 3 |
| West Cancer Center and Research Institute | Advanced Melanoma, Ovarian Cancer, Ovarian Neoplasms | 3 |
| Charles Retina Institute, P.C | AMD, Diabetic Retinopathy, DR, Gene Therapy | 2 |
| Conrad Pearson Clinic | Benign Prostatic Hyperplasia, NMIBC | 2 |
| Methodist Le Bonheur Healthcare | Aortic Stenosis, Aortic Stenosis, Calcific, Aortic Valve Stenosis | 2 |
| Stern Cardiovascular Center | Cardiotoxicity, Heart Failure, Percutaneous Coronary Intervention | 2 |
| Stern Cardiovascular Foundation | Heart Failure, Paroxysmal Atrial Fibrillation | 2 |
| Stern Cardiovascular Foundation, Inc. | Heart Failure, Heart Failure With Reduced Ejection Fraction, Hypertension | 2 |
| The Conrad Pearson Clinic - Wolf River Office (Urology Center of the South) | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 2 |
| The Stern Cardiovascular Foundation | Cardiovascular Disease and Lipoprotein(a), Diastolic Heart Failure, Heart Failure | 2 |
| West Cancer Center & Research Institute | Advanced Solid Tumor, Extensive-stage Small-cell Lung Cancer | 2 |
| A | Ankle Surgery, Foot Surgery | 1 |
| Baptist Memorial Hospital Memphis | Aortic Stenosis, Calcific, Aortic Valve Stenosis | 1 |
| Conrad Pearson-Memphis | FGFR Gene Alterations, FGFR Gene Amplification, FGFR3 Gene Alteration | 1 |
| Exelixis Clinical | Advanced Solid Tumor | 1 |
| GSK Investigational Site | Neoplasms, Head and Neck | 1 |
| Gastro One | Moderately to Severely Active Crohns Disease | 1 |
| Germantown, TN Investigative | Acute Heart Failure, Heart Failure | 1 |
| Germantown, Tennessee | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
Active & Upcoming Studies in Germantown (2026)
Recruiting trials in Germantown grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (39 active studies)
- A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · Phase 3 · Merck Sharp & Dohme LLC
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Cardiovascular (12 active studies)
- CCM OPEN HF Registry · Impulse Dynamics
- Novel On-body Evaluation of Cardiac Health for Oncology · Skribe Medical
Eye & vision (9 active studies)
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) · Phase 1 · Genentech, Inc.
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Neurology & pain (3 active studies)
- Reverse Shoulder Arthroplasty vs Rotator Cuff Repair for 60+ · Campbell Clinic
- Extended Oral Tranexamic Acid After Total Knee Arthroplasty · Phase 3 · Campbell Clinic
Diabetes & metabolic (1 active study)
Common conditions studied in Germantown
- Heart Failure (7 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Advanced Solid Tumor (2 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Neoplasms (2 active studies). Recruiting Breast Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Cervical Cancer (2 active studies). Recruiting Cervical Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Coronary Artery Disease (2 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
Leading research sponsors in Germantown
- Hoffmann-La Roche
- Merck Sharp & Dohme LLC
- Campbell Clinic
- AbbVie
- Genentech, Inc.
Local regulations and guidelines
Clinical trials in Tennessee are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Tennessee research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Germantown. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Germantown
Hipa.ai aggregates every recruiting study in Germantown from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Germantown?
There are approximately 91 recruiting clinical trials in Germantown, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Germantown pay participants?
Most recruiting trials in Germantown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Germantown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Germantown?
The most common conditions under active study in Germantown include Heart Failure (7), Breast Cancer (6), Advanced Solid Tumor (2), Breast Neoplasms (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Germantown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Germantown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Germantown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Germantown?
Recruiting research sites in Germantown include The West Clinic, PLLC dba West Cancer Center, Campbell Clinic, Charles Retina Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Germantown right now?
The largest active categories in Germantown are Cancer & tumors (39), Cardiovascular (12), Eye & vision (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.